Wed. Aug 10th, 2022

businessman holding sign indicating time to sell

Image Source: Getty Images

Again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sales reviews that caught my eye are summarized below. Here’s why top brokers believe investors should sell these stocks next week:

According to a note out of Swiss credit, its analysts have preserved theirs underperformers rating and $ 5.50 price target on the shares of this infant formula. Although it acknowledges that the prices of infant formulas are stabilizing, this is not enough to change the assessment. Especially given its concern about slowing down birth rates in China and loss of market share in the Stage 1 formula. A2 Milk shares ended the week at $ 6.02.

Magellan Financial Group Ltd. (ASX: MFG)

A note out of UBS reveals that its analysts have kept theirs sell rating and reduce their price target on this fund manager’s shares to $ 29.00. This follows the release of yet another disappointing fund under management update, which revealed further fund flows. The broker suspects that this is driven by the poor performance of its flagship Global Fund and fears that further outflows may occur. Especially on the retail side due to its poor performance and high fees. Magellan shares traded at $ 33.90 at Friday’s close.

Unibail-Rodamco-Westfield CDI (ASX: URW)

Analysts at Word Minnett have kept theirs sell rating and $ 4.00 price target on this mall operator shares. While Word Minnett notes that Unibail-Rodamco-Westfield shares have retreated meaningfully in recent months. It still does not see enough value in them to change its rating. Especially considering how it is yet to see evidence that there is an increase in trading conditions. As a result, it is sticking with its sales rating for the time being. The price of Unibail-Rodamco-Westfield ended the week at $ 4.94 today.

Leave a Reply

Your email address will not be published.